Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022116 (
ischemia
)
91,303
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We examined phosphatidylcholine (PC) effects on the isolated rat heart subjected to low- or zero-flow
ischemia
followed by reperfusion. Untreated hearts subjected to 30 min of low-flow
ischemia
recovered 15% contractility following reperfusion compared to time-control hearts. Phosphatidylcholine (0.005%) addition either 10 or 20 min before
ischemia
significantly enhanced recovery to approximately 61% and reduced the incidence of arrhythmias during
ischemia
and reperfusion. Contracture during
ischemia
and reperfusion was significantly reduced when PC was added 20 min before
ischemia
. Phosphatidylcholine was ineffective when administered at the time of reperfusion except for a moderate reduction in arrhythmia development. Phosphatidylcholine also produced a salutary effect when added 20 min prior to zero-flow
ischemia
. Subsarcolemmal mitochondria (SLM) and, to a much lesser degree, interfibrillar mitochondria (IFM) of untreated hearts subjected to low-flow
ischemia
and reperfusion exhibited depressed oxidative phosphorylation which was prevented by PC. Both mitochondrial populations exhibited a marked depression in
ADP/ATP translocase
activity; however, this was generally unaffected by PC. Subsarcolemmal mitochondria but not IFM of zero-flow ischemic reperfused hearts also exhibited significantly depressed oxidative phosphorylation, which was unaffected by PC. Zero-flow
ischemia
produced a rapid and total cessation of contractility. Both populations exhibited a substantial PC-insensitive reduction in translocase activity. Our results demonstrate, for the first time, a protection by PC on the reperfused ischemic heart. The PC-induced protection following low-flow but not zero-flow
ischemia
is associated with improved SLM oxidative phosphorylation suggesting dissimilar contribution of mitochondria to reperfusion-associated myocardial injury.
...
PMID:Protection of the reperfused ischemic isolated rat heart by phosphatidylcholine. 168 76
The possible relationship of the atractyloside-sensitive adenine nucleotide translocase activity, oxidative phosphorylation, and the recovery of ventricular contractility following reperfusion of the ischemic isolated rat heart was studied. Five minutes of total global
ischemia
without reperfusion produced a significant depression in adenine nucleotide translocase in subsarcolemmal mitochondria (SLM), whereas a minimum of 10 min
ischemia
was required to observe a significant depression in interfibrillar mitochondria (IFM). Increasing durations of
ischemia
resulted in a progressively larger depression in translocase activity, with a maximum depression of approximately 75% seen in both populations following 20 min
ischemia
. In contrast, oxidative phosphorylation was totally unaffected in either mitochondrial population following up to 20 min of
ischemia
. We assessed whether translocase activity or oxidative phosphorylation were related to contractile recovery in hearts reperfused following various durations of
ischemia
. In SLM, translocase activity was further depressed following reperfusion compared with pre-reperfusion ischemic values, whereas with IFM only reperfusion following 5 min
ischemia
produced a further depression in translocase values. Oxidative phosphorylation rates of SLM and IFM were significantly depressed following reperfusion of ischemic hearts, although SLM exhibited a generally higher sensitivity in this regard. In reperfused hearts, an overall significant relationship was found between oxidative phosphorylation rate and adenine translocase activity as well as between translocase activity and post-reperfusion contractile recovery. These data show that
ischemia
can produce a significant depression in translocase activity in the absence of any change in oxidative phosphorylation. The results also suggest that the depression in mitochondrial
ADP/ATP translocase
and subsequent inhibition of oxidative phosphorylation in the reperfused heart may represent one of the important contributory mechanisms involved in cardiac failure and injury during acute
ischemia
and reperfusion.
...
PMID:Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion. 254 94
The gene Aat coding for
ADP/ATP translocase
(
AAT
) was cloned from liver of the freeze-tolerant wood frog, Rana sylvatica, via differential screening of a cDNA library from liver of frozen frogs and using probes from control versus frozen frogs. Sequence analysis showed that clone pBfFR07 bearing the
AAT
cDNA contained a 1318-bp insert with one full-length open reading frame. The deduced amino acid sequence included 317 residues, with 81-86% identities to mammalian
AAT
. A 1750-nt transcript from the Aat gene was detected using pBfFR07 probe and a putative frog
AAT
of over 30 kDa was visualized by immunoblotting using a polyclonal antibody raised against chicken
AAT
. Analysis of liver samples from a time course of freezing showed a maximal 4.5-fold increase in mRNA after 8 h with
AAT
protein peaking in 24-h frozen frogs. Freezing also induced Aat expression in bladder and lung. In liver, mRNA expression also responded positively to anoxia stress but not to experimental dehydration of the animals. These results suggest that
AAT
induction during freezing may be stimulated by the
ischemia
that develops when plasma freezes; changes in
AAT
may contribute to stabilizing energetics in mitochondrial versus cytosolic pools over freeze/thaw cycles.
...
PMID:Differential regulation of the mitochondrial ADP/ATP translocase gene in wood frogs under freezing stress. 925 66